Non-small cell lung cancer metastatic
Not yet recruitingStudy Comparing Ivonescimab and Chemotherapy with Pembrolizumab and Chemotherapy for Patients with Metastatic Squamous Non-small Cell Lung Cancer
Study Comparing Ivonescimab and Chemotherapy with Pembrolizumab and Chemotherapy for Patients with Metastatic Squamous Non-small Cell Lung Cancer
- Disease:Non-small cell lung cancer metastatic
- Substances:CarboplatinIvonescimab+3
Spain- Participants:18–64 years · 65+ years
- Substances:Carboplatin
- Sponsor:Summit Therapeutics Inc.











